Ahmed Nagy is a Cardiology physician affiliated with University of Louisville. OpenAlex indexes 16 publications with 1,058 citations (h-index 12); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 Rose St
Lexington, KY 405360002
Telephone
859-323-0295Provider last certified this registry record 13 Jan 2025.
Clinical trials
- IV Dexmedetomidine vs Oral Gabapentin and Their Combination for Postoperative Analgesia in Cancer Patients Undergoing Modified Radical Mastectomy
Sponsor: National Cancer Institute, Egypt
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20253 payments
- Medtronic, Inc.Program year202419 payments
- Abbott LaboratoriesProgram year20245 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
46.7%Beta blocker28%Metoprolol Succinate100%Part D<11 patientsStatin18.7%Atorvastatin Calcium100%Part D<11 patientsBlood & clotting
37.3%Factor Xa inhibitor37.3%Eliquis100%Part D≥13 patientsMetabolism & gastrointestinal
16%SGLT2 inhibitor16%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Validation of Size Guides for Fitting Molar Bands to Stainless Steel Crowned Primary Molars.
PubMed
2023 - Measurement of Pharyngeal Residue From Lateral View Videofluoroscopic Images
Journal of Speech Language and Hearing Research
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Kelly McMasters, MD
University of Louisville
Stephen McClave, MD
University of Louisville
Robert Friedland, MD
University of Louisville
Charles Scoggins, MD
University of Louisville
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”